PF
Privium Fund Management B.V. 13F Holdings Tracker
Privium Fund Management B.V.Diversified strategyMomentum followerQuality / disciplined sizing
Total reported value
$480.3M
Reporting period: 2026-03-31 · Number of holdings: 60
Privium Fund Management B.V. disclosed 60 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $480.3M and a quarterly turnover rate of 25.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "P"
Personality snowflake
- Concentration
- 25.36
- Portfolio Stability
- 24.98
- Momentum/Contrarian
- 100
- Sector conviction
- 69.79
- Diversification
- 100
- Sizing Uniformity
- 83.11
Recent moves
Trim SHOP
-0.7% -$17.7M
Trim TSLA
-2.8% -$20.2M
Add IONS
+20.4% $2.7M
Trim SE
0.0% -$6.2M
Trim BIIB
-40.4% -$4.9M
Add ASTS
0.0% $1.5M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | Tesla INC | Stock-Consumer Disc | 17.18% | -1.74% | -2.84% | |
| 2 | SHOP | Shopify INC - Class A | Stock-Tech | 10.05% | -2.10% | -0.73% | |
| 3 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 6.76% | -0.51% | -1.47% | |
| 4 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 6.09% | -0.46% | — | |
| 5 | AMZN | Amazon.com INC | Stock-Consumer Disc | 5.42% | +0.28% | +3.31% | |
| 6 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 4.79% | -0.08% | -7.85% | |
| 7 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 4.53% | +1.02% | +20.43% | |
| 8 | LMND | Lemonade INC | Stock-Financials | 3.33% | +0.08% | +2.82% | |
| 9 | NVDA | Nvidia CORP | Stock-Tech | 2.94% | +0.16% | — | |
| 10 | COIN | Coinbase Global INC -class A | Stock-Financials | 2.87% | -0.42% | — | |
| 11 | AMD | Advanced Micro Devices | Stock-Tech | 2.63% | +0.26% | +3.33% | |
| 12 | ASTS | Ast Spacemobile INC | Stock-Tech | 2.50% | +0.56% | — | |
| 13 | SE | Sea Ltd-adr | Stock-Comm Services | 2.38% | -0.86% | — | |
| 14 | IREN | Iren LTD F | Stock-Other | 2.28% | +0.33% | +14.34% | |
| 15 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 2.07% | +0.16% | +3.25% | |
| 16 | ESPR | Esperion Therapeutics INC | Stock-Other | 1.88% | +1.88% | NEW | |
| 17 | ✓ | Proqr Thrapeutics N V | Stock-Other | 1.84% | -0.15% | +2.04% | |
| 18 | BIIB | Biogen INC | Stock-Healthcare | 1.67% | -0.71% | -40.39% | |
| 19 | QURE | uniQure N.V. | Stock-Other | 1.66% | -0.17% | +16.88% | |
| 20 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.59% | +0.08% | +2.04% | |
| 21 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 1.57% | -0.07% | +4.90% | |
| 22 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 1.09% | +1.09% | NEW | |
| 23 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 1.06% | +0.28% | +21.38% | |
| 24 | DNLI | Denali Therapeutics INC | Stock-Other | 1.02% | +1.02% | NEW | |
| 25 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.89% | -0.04% | +10.95% | |
| 26 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 0.84% | +0.84% | NEW | |
| 27 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.71% | -0.28% | — | |
| 28 | KRYS | Krystal Biotech INC | Stock-Healthcare | 0.60% | — | -8.22% | |
| 29 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.58% | +0.10% | -10.78% | |
| 30 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.52% | +0.09% | — | |
| 31 | BNTX | Biontech Se-adr | Stock-Other | 0.50% | -0.08% | -18.92% | |
| 32 | ✓ | Engene Holdings INC | Stock-Other | 0.50% | -0.09% | — | |
| 33 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.42% | +0.01% | — | |
| 34 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.38% | +0.09% | +6.06% | |
| 35 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.36% | -0.24% | +24.87% | |
| 36 | STOK | Stoke Therapeutics INC | Stock-Other | 0.34% | — | -9.09% | |
| 37 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.33% | — | -18.93% | |
| 38 | BEAM | Beam Therapeutics INC | Stock-Other | 0.32% | -0.04% | -10.51% | |
| 39 | MRNA | Moderna INC | Stock-Healthcare | 0.32% | — | -39.52% | |
| 40 | PFE | Pfizer INC | Stock-Healthcare | 0.31% | +0.14% | +39.55% | |
| 41 | LXEO | Lexeo Therapeutics INC | Stock-Other | 0.24% | -0.11% | +6.47% | |
| 42 | RNAC | Cartesian Therapeutics INC | Stock-Other | 0.23% | — | +3.83% | |
| 43 | MOH | Molina Healthcare INC | Stock-Healthcare | 0.23% | +0.23% | NEW | |
| 44 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 0.21% | — | +6.98% | |
| 45 | SLB | Slb LTD | Stock-Energy | 0.20% | -0.07% | -52.45% | |
| 46 | RCKT | Rocket Pharmaceuticals INC | Stock-Other | 0.18% | +0.07% | +42.32% | |
| 47 | HIMS | Hims & Hers Health INC | Stock-Healthcare | 0.17% | -0.07% | — | |
| 48 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.17% | — | +10.31% | |
| 49 | NOV | Nov INC | Stock-Energy | 0.16% | — | -20.89% | |
| 50 | RIG | Transocean Ltd. | Stock-Energy | 0.15% | — | -23.64% |
1–50 of 60
Portfolio Performance
Performance for Q3 2026
+7.6%
Performance Last 4 Quarters
+15.3%
Based on 66% of reported portfolio value with available pricing
- Stdev
- +23.7%
- Beta
- +1.27
- Alpha
- +3.6%
- Max Drawdown
- -23.1%
- Annualized Perf
- +27.3%
- Batting Avg vs S&P
- +63.9%
- Sortino
- +2.35
- Stutzer
- +0.34
- Treynor
- +0.21
- Sterling
- +1.11
- Calmar
- +1.18
- Information Ratio
- +0.49
- Tracking Error
- +17.3%
- Stdev Down
- +11.5%
- Winning Months %
- +58.3%
- Losing Months %
- +41.7%
- Best 12 Months
- +95.1%
- Worst 12 Months
- +11.3%
- Efficiency Ratio
- +0.51
- Sharpe
- +1.14
- Stdev Sectors
- +11.6%
- Skewness
- +0.28
- Kurtosis
- -0.19
- Upside Potential
- +4.18
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 60 | $480.3M | 25 | |
| 2025-12-31 | 57 | $543.1M | 30 | |
| 2025-09-30 | 59 | $556.3M | 52 | |
| 2025-06-30 | 55 | $463.5M | 0 | |
| 2025-03-31 | 56 | $383.6M | 0 | |
| 2024-12-31 | 64 | $441.9M | 0 | |
| 2024-09-30 | 82 | $402.0M | 0 | |
| 2024-06-30 | 129 | $392.1M | 0 | |
| 2024-03-31 | 117 | $374.5M | 0 | |
| 2023-12-31 | 114 | $359.0M | 0 | |
| 2023-09-30 | 115 | $336.2M | 0 | |
| 2023-06-30 | 69 | $127.0M | 0 | |
| 2023-03-31 | 126 | $297.7M | 0 | |
| 2022-12-31 | 150 | $263.7M | 0 | |
| 2022-09-30 | 226 | $275.2M | 0 | |
| 2022-06-30 | 252 | $301.8M | 0 | |
| 2022-03-31 | 279 | $452.4M | 0 | |
| 2021-12-31 | 253 | $504.3M | 0 |
Holding changes this quarter
Privium Fund Management B.V.'s most significant position changes for 2026-03-31: New buy: Esperion Therapeutics INC (ESPR); New buy: Biomarin Pharmaceutical INC (BMRN); New buy: Denali Therapeutics INC (DNLI); New buy: Alnylam Pharmaceuticals INC (ALNY); Sold out: Merck & Co. INC. (MRK).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IONS | Ionis Pharmaceuticals INC | +1% | +20.43% | Add |
| 2 | ASTS | Ast Spacemobile INC | +0.6% | — | Unchanged |
| 3 | IREN | Iren LTD F | +0.3% | +14.34% | Add |
| 4 | AMZN | Amazon.com INC | +0.3% | +3.31% | Add |
| 5 | VRTX | Vertex Pharmaceuticals INC | +0.3% | +21.38% | Add |
| 6 | AMD | Advanced Micro Devices | +0.3% | +3.33% | Add |
| 7 | NVDA | Nvidia CORP | +0.2% | — | Unchanged |
| 8 | AXSM | Axsome Therapeutics INC | +0.2% | +3.25% | Add |
| 9 | PFE | Pfizer INC | +0.1% | +39.55% | Add |
| 10 | ABEV | Ambev Sa-adr | +0.1% | -10.78% | Trim |
| 11 | MGTX | MeiraGTx Holdings plc | +0.1% | +6.06% | Add |
| 12 | ZLAB | Zai Lab Ltd-adr | +0.1% | — | Unchanged |
| 13 | LMND | Lemonade INC | +0.1% | +2.82% | Add |
| 14 | RARE | Ultragenyx Pharmaceutical In | +0.1% | +2.04% | Add |
| 15 | RCKT | Rocket Pharmaceuticals INC | +0.1% | +42.32% | Add |
| 16 | TDW | Tidewater INC | +0.1% | — | Unchanged |
| 17 | FATE | Fate Therapeutics INC | 0% | +12.25% | Add |
| 18 | CRSP | CRISPR Therapeutics AG | 0% | — | Unchanged |
| 19 | RNAC | Cartesian Therapeutics INC | — | +3.83% | Add |
| 20 | AUTL | Autolus Therapeutics PLC | 0% | +11.40% | Add |
| 21 | URGN | UroGen Pharma Ltd. | 0% | +10.95% | Add |
| 22 | BEAM | Beam Therapeutics INC | 0% | -10.51% | Trim |
| 23 | ARQT | Arcutis Biotherapeutics INC | -0.1% | +4.90% | Add |
| 24 | SLB | Slb LTD | -0.1% | -52.45% | Trim |
| 25 | HIMS | Hims & Hers Health INC | -0.1% | — | Unchanged |
| 26 | ARWR | Arrowhead Pharmaceuticals In | -0.1% | -7.85% | Trim |
| 27 | BNTX | Biontech Se-adr | -0.1% | -18.92% | Trim |
| 28 | ✓ | Engene Holdings INC | -0.1% | — | Unchanged |
| 29 | LXEO | Lexeo Therapeutics INC | -0.1% | +6.47% | Add |
| 30 | ✓ | Proqr Thrapeutics N V | -0.2% | +2.04% | Add |
| 31 | QURE | uniQure N.V. | -0.2% | +16.88% | Add |
| 32 | WVE | Wave Life Sciences Ltd. | -0.2% | +24.87% | Add |
| 33 | VRDN | Viridian Therapeutics INC | -0.3% | — | Unchanged |
| 34 | COIN | Coinbase Global INC -class A | -0.4% | — | Unchanged |
| 35 | PLTR | Palantir Technologies Inc-a | -0.5% | — | Unchanged |
| 36 | SPOT | Spotify Technology S.A. | -0.5% | -1.47% | Trim |
| 37 | BIIB | Biogen INC | -0.7% | -40.39% | Trim |
| 38 | SE | Sea Ltd-adr | -0.9% | — | Unchanged |
| 39 | TSLA | Tesla INC | -1.7% | -2.84% | Trim |
| 40 | SHOP | Shopify INC - Class A | -2.1% | -0.73% | Trim |
| 41 | ESPR | Esperion Therapeutics INC | — | NEW | New buy |
| 42 | BMRN | Biomarin Pharmaceutical INC | — | NEW | New buy |
| 43 | DNLI | Denali Therapeutics INC | — | NEW | New buy |
| 44 | ALNY | Alnylam Pharmaceuticals INC | — | NEW | New buy |
| 45 | MRK | Merck & Co. INC. | — | EXIT | Sold out |
| 46 | VZLA | Vizsla Silver CORP | — | EXIT | Sold out |
| 47 | MOH | Molina Healthcare INC | — | NEW | New buy |
| 48 | BTG | B2gold CORP | — | NEW | New buy |
| 49 | VAL | Valaris Limited | — | EXIT | Sold out |
| 50 | PAAS | Pan American Silver CORP | — | NEW | New buy |
FAQ
What is Privium Fund Management B.V. and what type of investor is it?
Privium Fund Management B.V. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $480.3M, spread across 60 disclosed positions.
What are Privium Fund Management B.V.'s largest equity positions?
Based on the latest 13F filing, Privium Fund Management B.V.'s top holdings by market value are:
1. Tesla INC (TSLA) — $82.5M (17.2%)
2. Shopify INC - Class A (SHOP) — $48.3M (10.1%)
3. Spotify Technology S.A. (SPOT) — $32.5M (6.8%)
4. Palantir Technologies Inc-a (PLTR) — $29.3M (6.1%)
5. Amazon.com INC (AMZN) — $26.0M (5.4%)
What changes did Privium Fund Management B.V. make in its most recent portfolio filing?
In the latest reported quarter, Privium Fund Management B.V. made 39 notable position adjustments: 7 new positions were initiated, 20 existing holdings were added to, 9 positions were partially reduced, and 3 were completely exited. The largest of these moves: New buy: Esperion Therapeutics INC (ESPR); New buy: Biomarin Pharmaceutical INC (BMRN); New buy: Denali Therapeutics INC (DNLI); New buy: Alnylam Pharmaceuticals INC (ALNY); Sold out: Merck & Co. INC. (MRK)
What sectors does Privium Fund Management B.V. focus on?
Privium Fund Management B.V. is concentrated in the following sectors based on its current disclosed equity portfolio:
• Information Technology: 29.6%
• Consumer Discretionary: 27.6%
• Health Care: 22.4%
• Communication Services: 11.2%
• Financials: 7.6%
• Energy: 0.8%
Peer Institutions
Institutions with a similar AUM
TW
Thomas White International LTD
CIK 0001092351
Total reported value
$480.3M
258 stks
2023-06-30
Stale — no recent filing
Concentration0.0
Portfolio Stability0.0
Sector conviction74.4
AUM within 0.0% of this institution
View detail
FC
Firestone Capital Management
CIK 0001799964
Total reported value
$480.3M
160 stks
2026-03-31
Concentration11.9
Portfolio Stability8.2
Sector conviction39.1
AUM within 0.0% of this institution
View detail
DA
Dash Acquisitions Inc.
CIK 0001745885
Total reported value
$480.2M
68 stks
2026-03-31
Concentration21.2
Portfolio Stability8.6
Sector conviction63.8
AUM within 0.0% of this institution
View detail
Similar Holdings Style
Institutions with overlapping top holdings
HB
Hudson Bay Capital Management LP
CIK 0001393825
Total reported value
$29.0B
1,607 stks
2026-03-31
Concentration9.9
Portfolio Stability63.4
Sector conviction62.8
3 of the top 5 holdings overlap, including Tesla INC
View detail
ARK Investment Management LLC
CIK 0001697748
Total reported value
$12.9B
182 stks
2026-03-31
Concentration10.4
Portfolio Stability28.4
Sector conviction54.9
3 of the top 5 holdings overlap, including Tesla INC
View detail
LS
Loomis Sayles & Co L P
CIK 0000312348
Total reported value
$74.3B
1,168 stks
2026-03-31
Concentration14.2
Portfolio Stability17.3
Sector conviction53.9
2 of the top 5 holdings overlap, including Tesla INC
View detail